Public Release: 

Institute for OneWorld Health awarded Skoll Foundation's Social Entrepreneurship Award

Institute for OneWorld Health

San Francisco, Calif. -March 21, 2005 - The Institute for OneWorld Health today announced that it has been awarded a 2005 Skoll Award for Social Entrepreneurship in the amount of $615,000 over three years. Based in San Francisco, OneWorld Health is the first nonprofit pharmaceutical company in the U.S. and develops new medicines to cure infectious diseases that disproportionately affect the poorest people in the world.

OneWorld Health is one of 13 organizations receiving $7.3 million from the Skoll Foundation through an open competitive process that identifies social entrepreneurs who have piloted innovative programs and are ready to take the next steps toward systemic social change. The awards will be presented on March 31 at the second annual Skoll World Forum on Social Entrepreneurship at Oxford University in England, where some of the world's leading practitioners and thought leaders in social entrepreneurship will convene to set the future agenda for visionaries who want to transform society.

"OneWorld Health is honored to be among this year's Skoll Award recipients," said Dr. Victoria Hale, founder and CEO of the Institute for OneWorld Health. "The Skoll Foundation recognizes the challenges each of our organizations face, and is leading the philanthropic community in its commitment to social innovators."

The Skoll Foundation's mission is to advance systemic change benefiting communities around the world by investing in, connecting and celebrating social entrepreneurs, who are individuals dedicated to creating new solutions that result in lasting improvements to complex social problems.

"We have cast our net far and wide to find the world's best social entrepreneurs," said Sally Osberg, President and CEO of the Skoll Foundation. "OneWorld Health is tackling a complex social problem in order to promote healthy, sustainable communities."

###

For more information about the winners of the Skoll awards, visit http://www.skollfoundation.org/grantees/index.asp.

The Institute for OneWorld Health, the first U.S. nonprofit pharmaceutical company, develops new, affordable medicines for infectious diseases that disproportionately affect people in the developing world, including visceral leishmaniasis, malaria, diarrhea and Chagas disease. OneWorld Health applies its entrepreneurial business model with a staff of experienced pharmaceutical scientists that identifies promising leads and drives development from pre-clinical studies to clinical trials through regulatory approval for diseases. The Institute for OneWorld Health, headquartered in San Francisco, Calif., is a tax-exempt 501(c) (3) U.S. corporation (http://www.oneworldhealth.org/). Media resources are available at http://www.oneworldhealth.org/media/index.php/.

Headquartered in Palo Alto, Calif., the Skoll Foundation was created in 1999 by Jeff Skoll, the first employee and first president of eBay. Its mission is to advance systemic change in communities around the world by investing in, connecting and celebrating social entrepreneurs, who are individuals dedicated to pioneering new solutions that result in lasting improvements to complex social problems.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.